Key Insights

Highlights

Success Rate

82% trial completion

Published Results

28 trials with published results (46%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

14.8%

9 terminated out of 61 trials

Success Rate

81.6%

-4.9% vs benchmark

Late-Stage Pipeline

34%

21 trials in Phase 3/4

Results Transparency

70%

28 of 40 completed with results

Key Signals

28 with results82% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (25)
P 1 (2)
P 2 (6)
P 3 (11)
P 4 (10)

Trial Status

Completed40
Terminated9
Unknown5
Withdrawn4
Recruiting2
Not Yet Recruiting1

Trial Success Rate

81.6%

Benchmark: 86.5%

Based on 40 completed trials

Clinical Trials (61)

Showing 20 of 20 trials
NCT06052956Phase 2Not Yet RecruitingPrimary

Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses

NCT06284473Phase 4Recruiting

Ketamine as a Supplement to Local Anesthesia for Minor Procedures

NCT05226260Not ApplicableCompleted

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care

NCT04241471Not ApplicableWithdrawnPrimary

Incision and Loop Drainage Utilizing a Novel Technique for Management of Cutaneous Abscess in an Adult Population

NCT05408624RecruitingPrimary

Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses

NCT02240498Phase 1CompletedPrimary

Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess Cavities

NCT03872700Phase 3CompletedPrimary

Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage

NCT05204537Completed

The Role of Surgery in Patients With Coronavirus Disease - 19 (COVID-19) Related Thoracic Complications

NCT05213949Unknown

An Observational Study of Risk Factors and Long-term Prognosis of Patients With Liver Abscess in the "Real-world"

NCT01252719Phase 3Completed

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)

NCT04957732Not ApplicableTerminatedPrimary

The Effect of Wound Irrigation With Irrisept on Abscess Healing (Irrisept UF Study)

NCT01076049Not ApplicableTerminated

The Effect of Irrisept for Irrigation of Skin and Soft Tissue Infections (Irrisept USF Study)

NCT01252732Phase 3Completed

Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection

NCT03127371Not ApplicableTerminatedPrimary

Adjunctive Nitrous Oxide During ED Incision and Drainage of Abscess

NCT00867789Not ApplicableTerminatedPrimary

Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department

NCT00691600Phase 3CompletedPrimary

Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage

NCT02410707Not ApplicableCompleted

Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults

NCT01673061Phase 4TerminatedPrimary

Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage

NCT01619410Not ApplicableTerminated

Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections

NCT04141787Phase 4Unknown

Ceftriaxone as Home IV for Staph Infections

Scroll to load more

Research Network

Activity Timeline